Beranda › Gangguan Depresi Mayor › Florida › Tampa
Uji klinis Gangguan Depresi Mayor di Tampa, FL
17 studi untuk Gangguan Depresi Mayor mencari peserta di lokasi sekitar Tampa (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
Menerima pesertaFase 2
- IPTB Clinical Research, Tampa
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Menerima pesertaFase 3
- K2 Medical Research Tampa, Tampa
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
Menerima pesertaFase 3
- K2 Medical Research (Tampa), Tampa
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
Menerima pesertaFase 3
- K2 Medical Research - Tampa, Tampa
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
Menerima pesertaFase 3
- IPTB Clinical Research, Tampa
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
Menerima pesertaFase 3
- Interventional Psychiatry of Tampa Bay, Tampa
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Menerima pesertaFase 3
- Psych Me Medical Research Inc, Tampa
- Interventional Psychiatry of Tampa Bay, Tampa
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
Menerima pesertaFase 2
- K2 Medical Research - Tampa, Tampa
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Menerima pesertaFase 4
- Neurocrine Clinical Site, Tampa
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
Menerima pesertaFase 2
- Draig Clinical Site, Tampa
- Draig Clinical Site, Tampa
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
Menerima peserta
- USF Health, Tampa
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Menerima pesertaFase 3
- Neurocrine Clinical Site, Tampa
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Menerima pesertaFase 3
- Neurocrine Clinical Site, Tampa
- Neurocrine Clinical Site, Tampa
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Menerima pesertaFase 3
- Neurocrine Clinical Site, Tampa
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
Menerima pesertaFase 2
- University of South Florida, Psychiatry and Behavioral Neurosciences, Tampa
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
Menerima pesertaFase 2
- Autobahn Site #148, Tampa
Study of ALTO-300 in MDD
Menerima pesertaFase 2
- Site 221, Tampa
Uji klinis Gangguan Depresi Mayor di kota lain
- New York City, NY36 studi
- Boston, MA31 studi
- Atlanta, GA25 studi
- Philadelphia, PA23 studi
- Orlando, FL19 studi
- Miami, FL18 studi
- Chicago, IL17 studi
- San Diego, CA16 studi
- Houston, TX16 studi
- Little Rock, AR14 studi
- Austin, TX13 studi
- Las Vegas, NV13 studi
Studi lain di Tampa
- Kanker Paru Non-Sel Kecil51 studi
- Kanker Payudara43 studi
- Kanker (semua jenis)39 studi
- Kanker Kolorektal34 studi
- Leukemia Mieloid Akut29 studi
- Kanker Metastatik29 studi
- Kanker Paru29 studi
- Kanker Pankreas26 studi
- Kanker Ovarium21 studi
- Melanoma19 studi
- Sindrom Mielodisplastik19 studi
- Kanker Prostat18 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.